Clinical Trial Update: Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intraperitoneal catumaxomab after complete surgical resection for gastric cancer with peritoneal carcinomatosis was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer with Peritoneal Carcinomatosis

Drugs mentioned

• Catumaxomab (Catumaxomab)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Patients With Gastric Peritoneal Carcinomatosis | Phase 2 | Status: TERMINATED